Hint mode is switched on Switch off
For swift navigation between sections

Sanofi Bonds, 1.875% 21mar2038, EUR (34) (FR0013324373)

Download
Copy issue information to clipboard
Copy issue information to clipboard
Copy to clipboard
Data copied to the clipboard

PDF download

Choose all Reset all
Download Cancel

Domestic bonds, Senior Unsecured

Issue | Issuer
Issuer
  • Scope
    ***  | ***
    ***
Status
Outstanding
Amount
1,250,000,000 EUR
Placement
***
Redemption (put/call option)
*** (-)
ACI on
Country of risk
France
Current coupon
***%
Price
-
Yield / Duration
-
Calculate in two clicks! yield, duration and other parameters
Calculate in two clicks! yield, duration and other parameters
Calculator What is a calculator?
Bid / Ask
/
Buy selected bonds via Exante trading platform Exante does not work with residents of the Russian Federation and the Republic of Belarus
BUY / SELL Registration on Cbonds is required
  • Placement amount
    1,250,000,000 EUR
  • Outstanding amount
    1,250,000,000 EUR
  • USD equivalent
    1,435,056,250 USD
  • Face value
    100,000 EUR
  • ISIN RegS
    FR0013324373
  • Common Code RegS
    179540428
  • CFI RegS
    DTFUFB
  • FIGI RegS
    BBG00K9ZVVS5
  • Ticker
    SANFP 1.875 03/21/38 20FX

explore the most comprehensive database

900 000

bonds globally

Over 400

pricing sources

80 000

stocks

116 000

ETF & Funds

track your portfolio in the most efficient way

  • Bond Search
  • Watchlist
  • Excel ADD-IN
Get access
×

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 900 000 bonds, 80 000 stocks, 116 000 ETF & Funds; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Register
×

Why

You will have detailed descriptive & pricing data for 650K bonds, 76K stocks, 8K ETFs
Get full access to the platform from any device & via Cbonds app
Enhance your portfolio management with Cbonds Excel Add-in
Build yield maps, make chart comparison within a click
Don't wait any longer — start using Cbonds today! Register

Files

Final Terms

Authorization required
It is only possible to download bond prospectuses for paid Premium subscription access

Trading chart

Stock exchange selection
Stock exchange selection
More about Cbonds Estimation
Data display in a chart | table
Data display in a chart | table
Work with the chart: switching the price, period, issue comparison
Work with the chart: switching the price, period, issue comparison
Customize fields in the table
Found:
Show all fields
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
* Data is not available within the selected subscription

Issue information

Profile
Sanofi SA, formerly Sanofi-Aventis, is a global and diversified healthcare company. The Company discovers, develops and distributes therapeutic solutions focused on patients needs. Sanofi focuses on the field of healthcare with six growth platforms: diabetes solutions, ...
Sanofi SA, formerly Sanofi-Aventis, is a global and diversified healthcare company. The Company discovers, develops and distributes therapeutic solutions focused on patients needs. Sanofi focuses on the field of healthcare with six growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets and animal health. Sanofi has a portfolio of prescription drugs, vaccines, generics and consumer healthcare products. In December 2011, Sanofi announced that it completed the divestiture of its dermatology business, Dermik, to Valeant Pharmaceuticals International, Inc. The Company is active domestically and abroad, including other European countries, North and Latin Americas, Asia, Africa and Middle East. As of January 31, 2012, the Companys major shareholder was Loreal with a stake of 8.82%.
Show more Hide
Research report by Cbonds-PRAAMS Save
Authorization required
Report download is available only paid Premium subscription access
Volume
  • Placement amount
    1,250,000,000 EUR
  • Outstanding amount
    1,250,000,000 EUR
  • Outstanding face value amount
    1,250,000,000 EUR
  • USD equivalent
    1,435,056,250 USD
Face value
  • Face value
    100,000 EUR
  • Outstanding face value
    *** EUR
  • Increment
    *** EUR

Cash flow parameters

  • Reference rate
    ***
  • Coupon Rate
    ***
  • Day count convention
    ***
  • Interest Accrual Date
    ***
  • Coupon frequency
    *** time(s) per year
  • Payment currency
    ***
  • Maturity date
    ***

Cash flow

Export to Excel

Early redemption terms

***

explore the most comprehensive database

900 000

bonds globally

Over 400

pricing sources

80 000

stocks

116 000

ETF & Funds

track your portfolio in the most efficient way

  • Bond Search
  • Watchlist
  • Excel ADD-IN
Get access
×

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 900 000 bonds, 80 000 stocks, 116 000 ETF & Funds; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Register
×

Why

You will have detailed descriptive & pricing data for 650K bonds, 76K stocks, 8K ETFs
Get full access to the platform from any device & via Cbonds app
Enhance your portfolio management with Cbonds Excel Add-in
Build yield maps, make chart comparison within a click
Don't wait any longer — start using Cbonds today! Register

Placement

  • Placement method
    Open subscription
  • Placement
    ***
  • Initial issue price (yield)
    (***%)
  • Bids
    *** EUR
  • Geographic breakdown
    ***
  • Investor breakdown
    ***
  • Use of proceeds
    General Corporate Purposes
    Acquisition Financing
  • Use of proceeds description
    The net proceeds of the issue of the Notes will be used for the general corporate purposes of the Issuer, including the financing of the acquisitions of Bioverativ and Ablynx
Participants
  • Bookrunner
    ***, ***, ***, ***, ***, ***, ***, ***, ***, ***
  • Depository
    ***
  • Arranger Legal Adviser (International law)
    ***

Conversion and exchange

  • Conversion terms
    ***

Latest issues

Show all

Similar issues

News

27/05/2025 Sanofi and VNVC Open Vaccine Manufacturing Hub in Vietnam
07/05/2025 Moody's Investors Service upgrades LT- local currency credit rating of Sanofi to "Aa3" from "A1"; outlook stable
07/05/2025 Moody's Investors Service upgrades LT- foreign currency credit rating of Sanofi to "Aa3" from "A1"; outlook stable
07/05/2025 Moody's Ratings upgrades Sanofi to Aa3; outlook stable (Rating action commentary)
28/04/2025 S&P Global Ratings affirms Sanofi at "AA" (Foreign Currency LT credit rating); outlook stable
All organization news

IFRS/US GAAP reports

2024
II q eng
IV q eng
2023
II q eng
IV q eng
2022
II q eng
IV q eng
2021
II q eng
IV q eng
2020
II q eng
IV q eng
2019
II q eng
IV q eng
2018
II q eng
IV q eng
2017
IV q eng
Show all Hide
Authorization required
You need to request access

Identifiers

  • ISIN RegS
    FR0013324373
  • Cbonds ID
    418425
  • Common Code RegS
    179540428
  • CFI RegS
    DTFUFB
  • FIGI RegS
    BBG00K9ZVVS5
  • WKN RegS
    A19X5N
  • Ticker
    SANFP 1.875 03/21/38 20FX
  • Type of security by CBR
    ***

Ratings

Bond classification

  • Senior Unsecured
  • Coupon bonds
  • Bearer
  • Amortization
  • Callable
  • CDO
  • Convertible
  • Dual currency bonds
  • Variable rate
  • For qualified investors (CIS region)
  • Foreign bonds
  • Green bonds
  • Guaranteed
  • Inflation-linked principal
  • Supranational bond issues
  • Inflation-linked coupon
  • Mortgage bonds
  • Non-complex financial instruments (MiFID)
  • Perpetual
  • Payment-in-kind
  • Non-Marketable Securities
  • Redemption Linked
  • Restructuring
  • Retail bonds
  • Covered
  • Securitization
  • Structured product
  • Commercial Bonds
  • Subordinated
  • Sukuk
  • Trace-eligible
Show more Hide

Restructuring

***

Holders

Registration is required to get access.